Regulations.gov document
Reference 10 - Guidance for Industry Providing Clinical Evidence of Effectiveness for…
Supporting & Related Material · FDA-2020-D-2101 · posted May 17, 2022
Key facts
| Document ID | FDA-2020-D-2101-0035 |
|---|---|
| Title | Reference 10 - Guidance for Industry Providing Clinical Evidence of Effectiveness for Human Drug and Biologic Products re Human Gene Therapy for Neurodegenerative Diseases; Draft Guidance for Industry |
| Document type | Supporting & Related Material |
| Subtype | Background Material |
| Agency | FDA |
| Docket | FDA-2020-D-2101 |
| Posted | May 17, 2022 |
At a glance
- 10–99 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: